Amanote Research

Amanote Research

    RegisterSign In

Phosphatidylinositol 3-Kinase-Δ (PI3K-δ) Is a Potential Therapeutic Target in Adult T-Cell Leukemia-Lymphoma

Biomarker Research - United Kingdom
doi 10.1186/s40364-018-0138-7
Full Text
Open PDF
Abstract

Available in full text

Categories
BiochemistryMolecular MedicineClinical Biochemistry
Date

July 18, 2018

Authors
Hiroo KatsuyaLucy B. M. CookAileen G. RowanYorifumi SatouGraham P. TaylorCharles R. M. Bangham
Publisher

Springer Science and Business Media LLC


Related search

Mitotic Kinase PBK/TOPK as a Therapeutic Target for Adult T‑cell Leukemia/Lymphoma

International Journal of Oncology
Cancer ResearchOncology
2018English

The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

Adult T-Cell Leukemia‐lymphoma

Hematology
Hematology
2012English

Adult T-Cell Leukemia/Lymphoma

2013English

Adult T-Cell Leukemia/Lymphoma

2019English

Adult T-Cell Leukemia/Lymphoma

Cancer
Cancer ResearchOncology
2002English

Adult T-Cell Leukemia/Lymphoma

English

Adult T-Cell Leukemia/Lymphoma

2008English

DUAL PI3K Δ/Γ INHIBITOR RP6530 IN PATIENTS WITH RELAPSED/REFRACTORY T-Cell LYMPHOMA: DOSE ESCALATION FINDINGS.

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy